SCHEDULE 13D JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the
Schedule 13D filed with the Securities and Exchange Commission on or about the
date hereof with respect to the beneficial ownership by the undersigned of the
Ordinary Shares, 50 xxxxx par value per share, of Amarin Corporation plc is
being filed, and all amendments thereto will be filed, on behalf of each of the
persons and entities named below, in accordance with Rule 13d-1 under the
Securities Exchange Act of 1934, as amended. This Agreement may be executed in
two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.
Dated as of October 26, 2009
Abingworth Bioventures V L.P.
By: Abingworth LLP
Its: Manager
By: /s/ Xxxxxxx X. Xxxxxx
---------------------------------------
Name: Xxxxxxx X. Xxxxxx
Title: Partner
Abingworth Bioventures V Co-Invest Growth
Equity Fund LP
By: Abingworth LLP
Its: Manager
By: /s/ Xxxxxxx X. Xxxxxx
---------------------------------------
Name: Xxxxxxx X. Xxxxxx
Title: Partner
Abingworth Bioequities Master Fund Limited
By: /s/ Xxxx X. Xxxxx
---------------------------------------
Name: Xxxx X. Xxxxx
Title: Authorized Signatory
Abingworth LLP
By: /s/ Xxxxxxx X. Xxxxxx
---------------------------------------
Name: Xxxxxxx X. Xxxxxx
Title: Partner